Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | NQO1 | P15559 | 1/20 | 0.31 |
| ▸ | CRHBP | P24387 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | CASP6 | P55212 | 1/20 | 0.31 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL879273 | 0.96 | TNKS (0.39) | TNKSPARP1TNKS2HDAC6PARP2 | |
| SCHEMBL18101684 | 0.94 | TNKS (0.39) | TNKSPARP1TNKS2HDAC6PARP2 | |
| SCHEMBL19051123 | 0.93 | ALOX5 (0.30) | — | |
| SCHEMBL9976985 | 0.92 | TNKS (0.36) | TNKSPARP1TNKS2HDAC6PARP2 | |
| SCHEMBL13171185 | 0.90 | TNKS (0.35) | TNKSPARP1TNKS2HDAC6PARP2 | |
| SCHEMBL17572976 | 0.89 | TNKS (0.38) | TNKSPARP1TNKS2HDAC6PARP2 | |
| SCHEMBL24195864 | 0.89 | TNKS (0.34) | TNKSPARP1TNKS2HDAC6PARP2 | |
| SCHEMBL4084424 | 0.88 | ALOX5 (0.32) | TNKSPARP1TNKS2HDAC6PARP2 | |
| SCHEMBL17573100 | 0.88 | MAOB (0.36) | TNKSPARP1TNKS2PARP2 | |
| SCHEMBL21940440 | 0.87 | TNKS (0.33) | TNKSPARP1TNKS2HDAC6PARP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190161497-A1 | SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES | IDEMITSU KOSAN CO., LTD. (JP) | 2019-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190161497-A1 | SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES | KCNQ2, KCNQ1, KCNQ4 | TNKS 3585/4885PARP1 1863/4885TNKS2 3491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.